Skip to main content
Premium Trial:

Request an Annual Quote

Proteomic Biomarker Shop CS-Keys Closes Seed Round of VC Financing

NEW YORK (GenomeWeb News) - Proteomics company CS-Keys said yesterday that it has received a "significant" but undisclosed seed investment from Midwest VC firm Triathlon Medical Ventures.
CS-Keys, based in Indianapolis, will use the investment to continue researching and developing its cancer-specific biomarkers and supporting its marketing and regulatory strategies.
Earlier this year, CS-Keys received a $285,000 investment from the BioCrossroads-managed Indiana Seed Fund. Triathlon is part of the Indiana Future Fund, a $73-million fund-of-funds organized through BioCrossroads and focused on early-stage Indiana life sciences investments.
CS-Keys was formed in February 2005 and is using proteomics techniques to create biomarkers for identifying malignant cells.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.